Long term outcome of hepatitis C viral (HCV) infection in primary adult liver transplant recipients compared to non HCV under tacrolimus

被引：0
|
作者：
Rogers, J [1 ]
Jain, A [1 ]
DeVera, M [1 ]
Yelochan, B [1 ]
Rakela, J [1 ]
Fung, J [1 ]
机构：
[1] Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00063
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
35
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [41] THE LONG-TERM OUTCOME OF JAPANESE RENAL ALLOGRAFT RECIPIENTS WITH HEPATITIS C VIRAL INFECTION
    Hirokatsu, Atsumi
    Yuki, Okushi
    Kazuaki, Okino
    Kiyotaka, Mukai
    Yuki, Matsui
    Keiji, Hujimoto
    Hiroki, Adachi
    Yoshihiro, Chikazawa
    Hiroshi, Okuyama
    Hideki, Yamaya
    Hitoshi, Yokoyama
    NEPHROLOGY, 2014, 19 : 55 - 55
  • [42] INCREASED INFECTIONS IN LIVER-TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS-C VIRUS (HCV) HEPATITIS
    SINGH, N
    GAYOWSKI, T
    WAGENER, MM
    MARINO, IR
    HEPATOLOGY, 1995, 22 (04) : 116 - 116
  • [43] Predicting early and long term patient and graft survival for liver transplant recipients with HCV infection - Results of the NIDDK liver transplant database.
    Charlton, MR
    Ruppert, K
    Belle, SH
    Nathan, BM
    Schafer, D
    Wiesner, RH
    Detre, KM
    Wei, Y
    Everhart, JE
    HEPATOLOGY, 2002, 36 (04) : 177A - 177A
  • [44] Survival outcome after retransplantation for recurrent hepatitis C viral (HCV) infection.
    Bozorgzadeh, A
    Jain, A
    Lansing, K
    Kashyap, R
    Orloff, M
    LIVER TRANSPLANTATION, 2004, 10 (06) : C6 - C6
  • [45] MONITORING T-CELL DIFFERENTIATION MARKERS IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C VIRUS (HCV) INFECTION
    Ortiz, Cecilia
    Berenguer, Marina
    Risalde, Bias
    Aguilera, Victoria
    Bueno, Carmen
    Prieto, Martin
    Carmona, Elena
    Sempere, Amparo
    Gonzalez-Molina, Andres
    Lopez-Labrador, Xavier
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 447 - 448
  • [46] HEPATITIS-C (HCV) INFECTION IN ORTHOTOPIC LIVER-TRANSPLANT (OLT) RECIPIENTS - EPIDEMIOLOGY AND NATURAL-HISTORY
    WEINSTEIN, JS
    RAKELA, J
    POTERUCHA, JJ
    LASKUS, T
    WIESNER, RH
    KROM, RAF
    PERSING, DH
    HEPATOLOGY, 1993, 18 (03) : 738 - 738
  • [47] Fibrosing cholestatic hepatitis in liver transplant (LT) recipients with hepatitis C virus (HCV) infection: Response to maintenance antiviral therapy.
    Deschenes, M
    Marcus, V
    Alpert, E
    Tchervenkov, J
    HEPATOLOGY, 2002, 36 (04) : 655A - 655A
  • [48] Invasive fungal infection in adult orthotopic liver transplant recipients under tacrolimus.
    Jonnalagadda, S
    Jain, AB
    Kusne, S
    Balan, V
    Khanna, A
    Rakela, J
    Starzl, T
    GASTROENTEROLOGY, 1996, 110 (04) : A1224 - A1224
  • [49] The Corrected Donor Age (CDA) for Hepatitis C virus (HCV) Infected Liver Transplant Recipients
    Biggins, Scott W.
    Dodge, Jennifer L.
    Gralla, Jane
    Bambha, Kiran
    Nydam, Trevor L.
    Rosen, Hugo R.
    Feng, Sandy
    Terrault, Norah
    HEPATOLOGY, 2013, 58 : 765A - 765A
  • [50] Bone-Related Outcomes among Liver Transplant (LT) Recipients with Hepatitis C (HCV)
    Lai, J. C.
    Terrault, N. A.
    Manos, M. M.
    LIVER TRANSPLANTATION, 2011, 17 (06) : S278 - S279
12345